Posted inAI
Five questions about FDA’s speedy rollout of AI for scientific review
Katie Palmer covers telehealth, clinical artificial intelligence, and the health data economy — with an…
Posted inAI
OpenAI and the FDA are reportedly discussing AI for drug evaluations
OpenAI has met with officials from the U.S. Food and Drug Administration to discuss the…
Posted inAI
Alibaba’s AI cancer detection tool clears FDA hurdle for faster approval process
Alibaba Group Holding’s research arm, Damo Academy, has secured a key endorsement from the US…
Posted inAI
Layoffs hit FDA’s Center for Devices and Radiological Health
WASHINGTON — The layoffs over the weekend at the Food and Drug Administration appear to…
Posted inAI
The FDA can help solve clinical AI’s trust problem
As 2025 begins, we are living in a Groundhog Day of distrust in clinical AI…
